University of Leeds
Improving cardiovascular care and outcomes: cross-boundary clinical registries and quality indicators
Abstract
dc:description.abstractCardiovascular registries have provided infrastructures for the conduction of observational and, in recent years, randomised research using routinely collected data. Clinical registries help identify gaps in care deliver, disparities in practice and stimulate quality improvement. However, the lack of integration between related registries increases the burden of data collection and limits the ability to combine data from different sources. Thus, there is a need to standardise the methods by which clinical data pertinent to cardiovascular disease (CVD) are defined and the quality of cardiovascular care is measured across various settings. The aim of this PhD is to harmonise the clinical definitions of the data variables for common cardiovascular conditions and interventions. Such a harmonisation is a prerequisite for the integration between cardiovascular registries and their interoperability with electronic health records. Thus, routinely collected data may be efficiently utilised for conducting quality improvement projects, high-quality clinical research and post-marketing surveillance of new drugs and devices. Under the auspice of the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart) initiative of the European Society of Cardiology (ESC), I led the establishment of a methodological process for the development of data standards for CVD. In addition, I applied this process and developed standardised clinical definitions for several cardiovascular domains, including acute coronary syndrome, percutaneous coronary intervention, heart failure, atrial fibrillation and transcatheter aortic valve implantation. I then participated in the implementation of the developed standards into the EuroHeart IT platform which has been adopted by a number of European countries. Furthermore, I led the construction of a standardised methodology for the development of quality indicators (QIs) for CVD. This methodology was used for the development of QIs for a variety of cardiovascular conditions, including acute myocardial infarction (AMI), atrial fibrillation, heart failure, CVD prevention and cardiac pacing. I then carried out external validation processes to evaluate the performance of some these QIs, such as AMI and heart failure, using data from national registries in Sweden and the UK. In conclusion, my PhD has been centred around the development, application and validation of methodological approaches for the construction of data standards and QIs for CVD. Such an endeavour not only addresses an unmet need in Europe, but also enables the conduction of international comparative analyses and clinical trials across the continent. The results of my PhD will provide a means for the generation of high-quality evidence that may help reduce the burden of CVD and improve patient outcomes.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Leeds
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Aktaa, Suleman
- Advisors dc:contributor.advisor
-
- Gale, Chris
- Munyombwe, Theresa
- Dondo, Tatendashe Bernadette
- ORCID person:identifier.orcid
Rights
- Language dc:language.dcterms_iso639_2
- eng
Identifiers
dc:identifier.*- Identifier
- uk.bl.ethos.858731